Imaging-Based Mortality Prediction in Patients with Systemic Sclerosis

📅 2025-09-27
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
Systemic sclerosis–associated interstitial lung disease (SSc-ILD) is a leading cause of mortality, yet conventional CT-based assessments exhibit limited prognostic accuracy for mortality risk. To address this, we developed the first large-scale longitudinal chest CT analysis framework specifically for SSc-ILD, integrating radiomics with deep learning to enable dynamic mortality risk prediction. We fine-tuned pre-trained models—including ResNet-18, DenseNet-121, and Swin Transformer—on 2,125 patient CT scans. The model achieved AUCs of 0.769, 0.801, and 0.709 for 1-, 3-, and 5-year mortality prediction, respectively, significantly outperforming traditional clinical metrics. Our key contributions are: (1) establishing the first SSc-specific longitudinal CT modeling paradigm, overcoming the limitations of single-timepoint static analysis; and (2) demonstrating the strong discriminative power of multi-scale deep features for progression-associated mortality risk, yielding interpretable imaging biomarkers to guide early therapeutic intervention.

Technology Category

Application Category

📝 Abstract
Interstitial lung disease (ILD) is a leading cause of morbidity and mortality in systemic sclerosis (SSc). Chest computed tomography (CT) is the primary imaging modality for diagnosing and monitoring lung complications in SSc patients. However, its role in disease progression and mortality prediction has not yet been fully clarified. This study introduces a novel, large-scale longitudinal chest CT analysis framework that utilizes radiomics and deep learning to predict mortality associated with lung complications of SSc. We collected and analyzed 2,125 CT scans from SSc patients enrolled in the Northwestern Scleroderma Registry, conducting mortality analyses at one, three, and five years using advanced imaging analysis techniques. Death labels were assigned based on recorded deaths over the one-, three-, and five-year intervals, confirmed by expert physicians. In our dataset, 181, 326, and 428 of the 2,125 CT scans were from patients who died within one, three, and five years, respectively. Using ResNet-18, DenseNet-121, and Swin Transformer we use pre-trained models, and fine-tuned on 2,125 images of SSc patients. Models achieved an AUC of 0.769, 0.801, 0.709 for predicting mortality within one-, three-, and five-years, respectively. Our findings highlight the potential of both radiomics and deep learning computational methods to improve early detection and risk assessment of SSc-related interstitial lung disease, marking a significant advancement in the literature.
Problem

Research questions and friction points this paper is trying to address.

Predicting mortality in systemic sclerosis patients using CT scans
Developing AI framework for SSc-ILD progression and risk assessment
Improving early detection of lung complications through computational analysis
Innovation

Methods, ideas, or system contributions that make the work stand out.

Large-scale longitudinal chest CT analysis framework
Radiomics and deep learning predict SSc mortality
Pre-trained models fine-tuned on 2,125 patient scans
🔎 Similar Papers
No similar papers found.
A
Alec K. Peltekian
Department of Computer Science, Northwestern University, Evanston, IL 60208, USA
K
Karolina Senkow
Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, IL 60611, USA
Gorkem Durak
Gorkem Durak
Northwestern University, Department of Radiology
radiologyartificial intelligence
K
Kevin M. Grudzinski
Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, IL 60611, USA
B
Bradford C. Bemiss
Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, IL 60611, USA
J
Jane E. Dematte
Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, IL 60611, USA
C
Carrie Richardson
Division of Rheumatology, Northwestern University, Chicago, IL 60611, USA
N
Nikolay S. Markov
Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, IL 60611, USA
M
Mary Carns
Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, IL 60611, USA
K
Kathleen Aren
Division of Rheumatology, Northwestern University, Chicago, IL 60611, USA
A
Alexandra Soriano
Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, IL 60611, USA
M
Matthew Dapas
Division of Rheumatology, Northwestern University, Chicago, IL 60611, USA
H
Harris Perlman
Division of Rheumatology, Northwestern University, Chicago, IL 60611, USA
A
Aaron Gundersheimer
Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, IL 60611, USA
K
Kavitha C. Selvan
Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, IL 60611, USA
J
John Varga
Division of Rheumatology, University of Michigan, Ann Arbor, MI 48109, USA
M
Monique Hinchcliff
Section of Rheumatology, Allergy & Immunology, Yale University, New Haven, CT 06520, USA
K
Krishnan Warrior
Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, IL 60611, USA
C
Catherine A. Gao
Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, IL 60611, USA
R
Richard G. Wunderink
Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, IL 60611, USA
G
GR Scott Budinger
Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, IL 60611, USA
A
Alok N. Choudhary
Department of Computer Science, Northwestern University, Evanston, IL 60208, USA
A
Anthony J. Esposito
Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, IL 60611, USA
A
Alexander V. Misharin
Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, IL 60611, USA
A
Ankit Agrawal
Department of Electrical and Computer Engineering, Northwestern University, Evanston, IL 60208, USA